REGiMMUNE Corporation
A biotechnology company producing immune-regulatory therapeutics for life-threatening diseases and debilitating disorders. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
AUD71m (Public information from Apr 2017)
Tokyo Japan (HQ)
Authorizing premium user...